| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 2 | -65.8K | 100% | $3.86 | -$254K |
| Net | -2 | -65.8K | -100% | -$254K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Sanford Robertson | Director | $25.2M | May 16, 2024 | ||
| Richard Barry | President & CEO, Director | $20.5M | Oct 1, 2024 | ||
| Freda Nassif | Chief Commercial Officer | $1.69M | Nov 18, 2024 | ||
| James William Kupiec | Chief Medical Officer | $1.69M | -$15.5K | -0.91% | Nov 29, 2024 |
| Robert Christopher Cook | SVP & General Counsel | $1.69M | Sep 6, 2024 | ||
| Jaren Landen | Chief Clinical Dev. Officer | $1.43M | Nov 18, 2024 | ||
| Remi Barbier | President & CEO, Director | $844K | May 20, 2024 | ||
| Robert Z. Gussin | Director | $253K | May 9, 2024 | ||
| Patrick J. Scannon | Director | $186K | May 9, 2024 | ||
| Michael J. O. Donnell | Director | $169K | May 9, 2024 | ||
| Robert Eugene Anderson Jr | Director | $169K | May 9, 2024 | ||
| Pierre Gravier | Director | $169K | May 9, 2024 | ||
| Claude Nicaise | Director | $169K | May 9, 2024 | ||
| Eric Schoen | Chief Financial Officer | $44.4K | -$238K | -84.3% | Nov 29, 2024 |
| Nadav Friedmann | Chief Medical Officer, Director | $2.5K | Dec 31, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|